<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04577690</url>
  </required_header>
  <id_info>
    <org_study_id>1000065122</org_study_id>
    <nct_id>NCT04577690</nct_id>
  </id_info>
  <brief_title>PECS Study for CIED Implantation Surgery</brief_title>
  <official_title>Pectoral Nerve (PECS) Block for Cardiac Implantable Electronic Devices (CIED) Implantation Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to determine whether pectoral nerve block (PECS) performed after induction of&#xD;
      anesthesia but before surgical incision results less opioid use in the post operative period&#xD;
      compared with local infiltration alone in children undergoing Cardiac Implantable Electronic&#xD;
      Device (CIED) surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current anaesthetic management of CIED surgery at Sickkids is local anaesthetic&#xD;
      infiltration by the EP cardiologist or a Pectoral nerve block (PECS) on an ad-hoc basis&#xD;
      depending on the anaesthesiologist on a case by case basis. It is not known whether one&#xD;
      technique provides better post- operative pain control and fewer adverse events than the&#xD;
      other. In either case, the patient receives opioids as required during and after the&#xD;
      procedure. Patients typically go home with a prescription for opioids to be taken for the&#xD;
      first few days after surgery.&#xD;
&#xD;
      The PECS block is a recognized effective anaesthetic technique used for both intraoperative&#xD;
      and postoperative pain control in adult breast surgery, chest wall procedures as well as one&#xD;
      case report for CIED implantation and a small series in paediatric cardiac surgery. The&#xD;
      advantages of the PECS block in these surgical procedures includes improved analgesia and&#xD;
      reduced opioid use.&#xD;
&#xD;
      The investigators plan to conduct an RCT with two groups.&#xD;
&#xD;
      Group 1 will receive a PECS block (using 0.8 ml/kg of 0.25% bupivacaine with epinephrine 1:&#xD;
      200000 divided in two equal volumes between the two planes) by the anaesthesiologist and&#xD;
      local infiltration (up to 0.2 ml/kg of 0.25% bupivacaine with epinephrine 1:200000) by the&#xD;
      surgeon.&#xD;
&#xD;
      Group 2 will receive local infiltration (up to 0.8 ml/kg 0.25 % bupivacaine with epinephrine&#xD;
      1:200000) by the surgeon alone.&#xD;
&#xD;
      Both groups will be given opioids as rescue analgesics as deemed necessary during their&#xD;
      procedure and as rescue analgesia postoperatively, so that no patient will have untreated&#xD;
      pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Using a computer-generated table, patients will be randomized to one of two groups: PECS block or Local infiltration only. Group allocation are concealed in sealed, opaque, sequentially numbered envelopes that are opened on the day of surgery.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>The nursing staff in the post anesthesia care unit, patient and outcome assessors will be blinded to the patient allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative morphine consumption</measure>
    <time_frame>0 hours</time_frame>
    <description>Amount of morphine or morphine equivalents used after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of pain</measure>
    <time_frame>0 hours, 6 hours, 12 hours and at discharge from hospital</time_frame>
    <description>Severity of pain will be measured using and Numerical Rating Score (NRS) or Face, Legs, Activity, Cry and Consolability (FLACC) score as appropriate for age.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of nausea/emesis postoperatively</measure>
    <time_frame>Until discharge from recovery room, assessed up to 2 days</time_frame>
    <description>Any self-reported episodes of nausea and any emesis will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of pruritus</measure>
    <time_frame>Until discharge from recovery room, assessed up to 2 days</time_frame>
    <description>Any self-reported episodes of pruritus will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Until discharge from recovery room, assessed up to 2 days</time_frame>
    <description>Any occurrence of hematoma, pneumothorax, lung injury or local anesthesia toxicity will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to discharge from recovery room</measure>
    <time_frame>Until discharge from recovery room, assessed up to 2 days</time_frame>
    <description>Time from admission to recovery room to discharge from recovery room</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Child</condition>
  <condition>Adolescent</condition>
  <arm_group>
    <arm_group_label>PECS block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A PECS block of 0.25 % bupivacaine with epinephrine 1:200000 (below the toxic dose limit of 3 mg/kg) in divided doses to cover the fascial planes identified in PECS I and PECS II. At the completion of surgery, the wound will be infiltrated with up to 0.2 ml/kg of 0.25 % bupivacaine into the wound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At the completion of surgery, the EP cardiologist will infiltrate the wound with up to 0.8 ml/kg of 0.25 % bupivacaine with epinephrine 1:200000.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.25% with epinephrine 1:200000 by PECS block and wound infiltration</intervention_name>
    <description>The anesthesiologist will administer bupivacaine 0.25% with epinephrine 1:200000 by PECS block after induction of anesthesia before surgical incision. The EP cardiologist will also administer bupivacaine 0.25% with epinephrine 1:200000 by infiltrating the wound after surgery is complete.</description>
    <arm_group_label>PECS block</arm_group_label>
    <other_name>PECS block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.25% with epinephrine 1:200000 by wound infiltration only</intervention_name>
    <description>The EP cardiologist will administer Bupivacaine 0.25% with epinephrine 1:200000 by infiltrating the wound after surgery is complete.</description>
    <arm_group_label>Infiltration</arm_group_label>
    <other_name>Infiltration</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        â€¢ All patients 3-18 years undergoing CIED surgery in the chest&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children &lt; 3 years of age at time of procedure as bupivacaine is not licensed for this&#xD;
             age group.&#xD;
&#xD;
          -  No parental or patient consent&#xD;
&#xD;
          -  Allergy to bupivacaine&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Any condition or diagnosis, that could in the opinion of the Principal Investigator or&#xD;
             delegate interfere with the participant's ability to comply with study instructions,&#xD;
             might confound the interpretation of the study results, or put the participant at&#xD;
             risk.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine Taylor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katherine Taylor</last_name>
    <phone>416-813-7445</phone>
    <email>katherine.taylor@sickkids.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carolyne Pehora</last_name>
    <phone>416-813-7654</phone>
    <phone_ext>202406</phone_ext>
    <email>carolyne.pehora@sickkids.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Taylor</last_name>
      <phone>416-813-7445</phone>
      <email>katherine.taylor@sickkids.ca</email>
    </contact>
    <contact_backup>
      <last_name>Carolyne Pehora</last_name>
      <phone>416-813-7654</phone>
      <phone_ext>202406</phone_ext>
      <email>carolyne.pehora@sickkids.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Anica Bulic</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Farrukh Munshey</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Froyshteter AB, Bhalla T, Tobias JD, Cambier GS, Mckee CT. Pectoralis blocks for insertion of an implantable cardioverter defibrillator in two patients with Duchenne muscular dystrophy. Saudi J Anaesth. 2018 Apr-Jun;12(2):324-327. doi: 10.4103/sja.SJA_624_17.</citation>
    <PMID>29628849</PMID>
  </reference>
  <reference>
    <citation>Fujiwara A, Komasawa N, Minami T. Pectoral nerves (PECS) and intercostal nerve block for cardiac resynchronization therapy device implantation. Springerplus. 2014 Aug 5;3:409. doi: 10.1186/2193-1801-3-409. eCollection 2014.</citation>
    <PMID>25120950</PMID>
  </reference>
  <reference>
    <citation>Al Ja'bari A, Robertson M, El-Boghdadly K, Albrecht E. A randomised controlled trial of the pectoral nerves-2 (PECS-2) block for radical mastectomy. Anaesthesia. 2019 Oct;74(10):1277-1281. doi: 10.1111/anae.14769. Epub 2019 Jul 4.</citation>
    <PMID>31273773</PMID>
  </reference>
  <reference>
    <citation>AltÄ±parmak B, Korkmaz Toker M, Uysal AÄ°, Turan M, GÃ¼mÃ¼ÅŸ Demirbilek S. Comparison of the effects of modified pectoral nerve block and erector spinae plane block on postoperative opioid consumption and pain scores of patients after radical mastectomy surgery: A prospective, randomized, controlled trial. J Clin Anesth. 2019 May;54:61-65. doi: 10.1016/j.jclinane.2018.10.040. Epub 2018 Nov 3.</citation>
    <PMID>30396100</PMID>
  </reference>
  <reference>
    <citation>Amir A, Jolin S, Amberg S, Nordstrom S. Implementation of Pecs I and Pecs II Blocks as Part of Opioid-Sparing Approach to Breast Surgery. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):544-5. doi: 10.1097/AAP.0000000000000401.</citation>
    <PMID>27315180</PMID>
  </reference>
  <reference>
    <citation>Bashandy GM, Abbas DN. Pectoral nerves I and II blocks in multimodal analgesia for breast cancer surgery: a randomized clinical trial. Reg Anesth Pain Med. 2015 Jan-Feb;40(1):68-74. doi: 10.1097/AAP.0000000000000163.</citation>
    <PMID>25376971</PMID>
  </reference>
  <reference>
    <citation>Blanco R. The 'pecs block': a novel technique for providing analgesia after breast surgery. Anaesthesia. 2011 Sep;66(9):847-8. doi: 10.1111/j.1365-2044.2011.06838.x.</citation>
    <PMID>21831090</PMID>
  </reference>
  <reference>
    <citation>Kumar KN, Kalyane RN, Singh NG, Nagaraja PS, Krishna M, Babu B, Varadaraju R, Sathish N, Manjunatha N. Efficacy of bilateral pectoralis nerve block for ultrafast tracking and postoperative pain management in cardiac surgery. Ann Card Anaesth. 2018 Jul-Sep;21(3):333-338. doi: 10.4103/aca.ACA_15_18.</citation>
    <PMID>30052231</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 28, 2020</study_first_submitted>
  <study_first_submitted_qc>October 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>October 2, 2020</last_update_submitted>
  <last_update_submitted_qc>October 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>Katherine Taylor</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

